🇪🇸·6d agoIndustry
Lebrikizumab delivered significant skin clearance and improved disease severity in children with moderate-to-severe atopic dermatitis
Publisher
A
Almirall (IR News)
Spain
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on almirall.com
Leave the platform to read the original full article on the publisher site.
Source: Almirall (IR News)
Scope: Industry
Related coverage
More related coverage
Stiefel (GSK)·2d ago
View latest results
AHA (Heart Association)·1d ago
Hospitals drive progress in Japan’s heart failure care
RAPS News·1d ago
This Week at FDA: FDA seeks input on CNPV, new approvals, and more
Skpharmteco·1d ago